Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0000935836-25-000396

Chief Clinical Officer acquired 57,380 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Langsam Jeffrey · Chief Clinical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-21 Grant or award : show line 1 in the form +57,380 57,380 D
Loading xslF345X05/ownership.xml…